PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 15, 20260 citationsOpen Access

Luoshu-Markov Geometric Framework: Fiedler Eigenvalue for Druggability Prediction, Allosteric Site Discovery, and Vina Discrepancy Correction (n=123)

View Full Paper
YKYao-Kai Kao

Key Points

  • The study aims to enhance druggability prediction and allosteric site discovery using a Markov-Fiedler framework.
  • Analyzed 123 DUD-E proteins (87 druggable, 36 undruggable) using the Fiedler eigenvalue of the residue-contact graph Laplacian.
  • Conducted a combined model evaluation with 5-fold cross-validation to calculate AUC.
  • Performed discrepancy analysis for CDK2 using Vina to explain binding gap in specific interactions.
  • The Fiedler eigenvalue significantly distinguishes druggable (0.057) from undruggable proteins (0.090, Mann-Whitney p=0.0028).
  • The combined model achieved a 5-fold CV AUC of 0.8393.
  • CDK2 Vina analysis identified an entropic gap of +3.13 kcal in binding assessments.

Abstract

We introduce the Markov-Fiedler spectral complement to the Lo-Shu druggability framework. For n=123 DUD-E proteins (87 druggable, 36 undruggable), the Fiedler eigenvalue lambda2 of the residue-contact graph Laplacian significantly distinguishes druggable from undruggable proteins (drug=0.057 vs undrug=0.090, Mann-Whitney p=0.0028). Combined model achieves 5-fold CV AUC=0.8393. Lo-Shu Markov allosteric score recovers validated allosteric proteins (cMyc-Max, CaM, HIF-1alpha, XIAP, PTPB) from structural geometry alone. CDK2 Vina discrepancy analysis explains BMS387032 gap (+3.13 kcal) via entropic N/C lobe boundary binding.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yao-Kai Kao (2026) studied this question.

synapsesocial.com/papers/6a06b928e7dec685947abb14https://doi.org/10.5281/zenodo.20152193
Ask AI
Helpful
Bookmark
Share
View Full Paper